Neurology Medical News about Antimigraine drugs

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Antimigraine drugs: new frontiers
Neurological Sciences, 05/12/09

Rapoport A - There are many acute care and preventive medications for the treatment of migraine. However, patients may often find that their headaches are not under optimal control. There are several targets that have been looked at and studied for the production of new, more effective medications. There are also effective devices for therapy of migraine. A list of targets will be put forth and a small number of them will be described in greater detail in this paper.

Exclusive Author Commentary
A. Rapoport, 06/02/09

This article presents a few of the most exciting up and coming therapies in migraine. A new category of acute treatment, CGRP antagonism is detailed. Then there are 3 older medications that will soon be able to be given in a different route: sumatriptan by patch, DHE by oral inhalation and ketorolac by nasal spray. For chronic headache, occipital nerve stimulation is being investigated. Alan Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA, Los Angeles, CA

<< Previous
Validity of Self-reported Stroke in Elderly African Americans,...

Next >>
Combined targeting of interleukin-6 and vascular endothelial...

Psychotropic Drug Use During Breastfeeding: A Review of the Evidence
Pediatrics, 10/01/09 Relevance Score: 49%

An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists
Clinical Therapeutics, 10/15/09 Relevance Score: 48%

Online Illegal Drug Use Information: An Exploratory Analysis of Drug-Related Website Viewing by Adolescents
Journal of Health Communication, 10/29/09 Relevance Score: 47%

Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain
AIDS Research and Human Retroviruses, 10/23/09 Relevance Score: 46%

Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial
Journal of Clinical Oncology, 10/16/09 Relevance Score: 46%